08:00 , Jan 25, 2016 |  BC Week In Review  |  Company News

Genetic Analysis, Biohit deal

Genetic Analysis granted Biohit the right to sell Genetic Analysis’ Dysbiosis Test, which can identify imbalances in the gut microbiota, worldwide under the Biohit brand and exclusively in Finland and China. The test has CE...
07:00 , Sep 8, 2014 |  BC Week In Review  |  Clinical News

GastroPanel regulatory update

Biohit said Chinese health associations The Chinese Society of Digestive Endoscopy and The Society of Ontological Endoscopy of Chinese Anti-Cancer Association issued a consensus clause recommending serum screening with Pepsinogen I and II, Gastrin-17 and...
07:00 , Mar 31, 2014 |  BC Week In Review  |  Company News

Biohit sales and marketing update

Biohit launched its Calprotectin test in Europe, the Middle East and Asia for early detection and monitoring of inflammatory bowel disease (IBD), such as Crohn's disease and ulcerative colitis. The test measures fecal calprotectin levels...
08:00 , Nov 25, 2013 |  BC Week In Review  |  Company News

Advanced Biomedical Systems, Biohit deal

Biohit acquired exclusive, worldwide development and commercialization rights to the UFT300 test for Helicobacter pylori infection from Advanced Biomedical for €350,000 ($472,605). UFT300 detects H. pylori urease activity in gastric biopsy specimens. The company said...
07:00 , Aug 19, 2013 |  BC Week In Review  |  Company News

Biohit sales and marketing update

Biohit launched in Europe a test to diagnosis celiac disease from a fingertip blood sample. The test, which has CE Mark approval, determines human tissue transglutaminase (TGM) for IgA, IgG and IgM antibodies. Biohit said...
07:00 , Jul 15, 2013 |  BC Week In Review  |  Company News

Biohit, Anhui Wisdom-Win Investment Co. Ltd. deal

Biohit and Anhui Wisdom-Win formed a JV, Biohit Biotech (Hefei) Co. Ltd. (Hefei, China), to manufacture and commercialize Biohit's GastroPanel kits in China. Biohit will own 40% of the newco, while Anhui Wisdom-Win will own...
07:00 , Jul 1, 2013 |  BC Week In Review  |  Company News

Biohit, IBL International GmbH sales and marketing update

Biohit Oyj (HSE:BIOBV), Helsinki, Finland   IBL International GmbH , Hamburg, Germany   Business: Diagnostic   Biohit granted IBL exclusive rights to distribute Biohit's GastroPanel in Germany. Biohit says the non-invasive blood test can diagnose...
07:00 , Apr 22, 2013 |  BC Week In Review  |  Company News

Biohit, Euroclone S.p.A. deal

Diagnostic company Biohit acquired Euroclone's Euroclone Gastro s.r.l. gastrointestinal diagnostics subsidiary for 180,000 new Biohit shares, or about €1.1 million ($1.5 million) based on Biohit's close of €6.26 on April 17, the day before the...
08:00 , Dec 17, 2012 |  BC Week In Review  |  Company News

Biohit management update

Biohit Oyj (HSE:BIOBV), Helsinki, Finland   Business: Diagnostic   Appointed: Kari Syrajanen as chief medical director  ...
07:00 , Oct 1, 2012 |  BioCentury  |  Finance

3Q Stock Wrap-Up: Back in black

Large cap biotechs stormed back after a weak 2Q12 to post a 7% gain for a third quarter in which every market cap segment finished in the black, albeit just barely for the micro-caps. For...